ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
162 hedge funds and large institutions have $1.47B invested in Acorda Therapeutics in 2014 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 63 increasing their positions, 45 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
6% less capital invested
Capital invested by funds: $1.57B → $1.47B (-$95M)
38% less call options, than puts
Call options by funds: $2.85M | Put options by funds: $4.62M
Holders
162
Holding in Top 10
1
Calls
$2.85M
Puts
$4.62M
Top Buyers
| 1 | +$37.8M | |
| 2 | +$23.8M | |
| 3 | +$19.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.2M |
| 5 |
Jennison Associates
New York
|
+$14.1M |
Top Sellers
| 1 | -$35.7M | |
| 2 | -$29.1M | |
| 3 | -$27.4M | |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$22.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$13.6M |